Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$0.68 - $1.25 $7,145 - $13,135
10,508 New
10,508 $7,000
Q3 2022

Oct 14, 2022

SELL
$1.02 - $2.23 $510 - $1,115
-500 Reduced 4.72%
10,100 $13,000
Q2 2022

Jul 13, 2022

SELL
$0.94 - $1.94 $159 - $329
-170 Reduced 1.58%
10,600 $11,000
Q1 2022

May 12, 2022

SELL
$1.54 - $3.71 $45,160 - $108,795
-29,325 Reduced 73.14%
10,770 $21,000
Q4 2021

Feb 10, 2022

SELL
$2.58 - $3.91 $39,342 - $59,623
-15,249 Reduced 27.55%
40,095 $107,000
Q3 2021

Oct 14, 2021

SELL
$2.77 - $4.05 $11,927 - $17,439
-4,306 Reduced 7.22%
55,344 $188,000
Q2 2021

Aug 12, 2021

SELL
$1.71 - $4.14 $17,100 - $41,400
-10,000 Reduced 14.36%
59,650 $229,000
Q1 2021

Apr 22, 2021

BUY
$0.85 - $5.27 $24,344 - $150,932
28,640 Added 69.84%
69,650 $184,000
Q4 2020

Apr 01, 2021

BUY
$0.36 - $0.95 $10,983 - $28,984
30,510 Added 290.57%
41,010 $35,000
Q2 2019

Aug 14, 2019

BUY
$1.81 - $2.45 $19,005 - $25,725
10,500 New
10,500 $21,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $526M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.